Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Privia Health Group Inc(PRVA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PRVA
11/04/2026: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Privia Health Group Inc is a growth-oriented company that provides technology and administrative services to help independent physicians transition to value-based care models. Its primary strength lies in its scalable, capital-efficient platform which has fostered a high degree of provider loyalty and consistent network growth. The main investment story centers on the ongoing shift in the U.S. healthcare system toward outcomes-based reimbursement. Risks include potential regulatory changes, intense competition from integrated health systems, and the operational challenges of scaling across new regions. The stock may best suit growth-focused investors, and market participants should monitor the company's ability to maintain high performance under new commercial risk-sharing contracts.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Privia is scaling rapidly in the transition to value-based care, making it a compelling target for growth-oriented portfolios. |
| Momentum investor | Mixed fit | Performance is subject to health sector sentiment and regulatory news flow, necessitating a positive trend signal. |
| Value investor | Weak fit | The company is in a high-growth phase and does not focus on traditional valuation metrics like P/E ratios. |
| Dividend investor | Weak fit | Privia does not pay a dividend, preferring to reinvest all capital back into the business. |
| Low-risk investor | Weak fit | Healthcare policy shifts and market competition introduce high volatility that may not suit conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Growth stocks in the healthcare sector often experience significant price swings based on earnings results and policy updates. |
| Valuation risk | Medium / high | Market pricing often reflects high growth expectations, leaving little room for error if performance slows. |
| Competition risk (Value-based care enablement) | High | The sector is crowded with well-funded competitors and systems that can quickly encroach on Privia's target physician base. |
| Business quality | Medium | The company has a strong, repeatable model, but it remains dependent on the success of individual medical practices. |
| Dividend income | Low / none | Investors should not look to PRVA for income as it retains all earnings for growth. |
| Execution risk | Medium / high | Successful scaling depends on the effective integration of technology and physician culture across multiple regions. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -24.54% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/04/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.74B USD | Price to earnings Ratio 102.24 | 1Y Target Price 31.47 |
Price to earnings Ratio 102.24 | 1Y Target Price 31.47 | ||
Volume (30-day avg) 1.3M shares | Beta 0.75 | 52 Weeks Range 18.91 - 28.82 | Updated Date 11/04/2026 |
52 Weeks Range 18.91 - 28.82 | Updated Date 11/04/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.21 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Physician Enablement | Service fees and performance-based incentives generated through the Privia Platform. | Privia gets paid when they help doctors save money and improve care for patients. |
| Geography (U.S.) | Operations across various U.S. states where Privia supports physician networks. | The company's success is tied to its ability to win and support doctors across different U.S. regions. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When Before Market | Estimate 0.09 | Actual - |
Profitability
Profit Margin 1.19% | Operating Margin (TTM) 1.86% |
Management Effectiveness
Return on Assets (TTM) 2.03% | Return on Equity (TTM) 4.31% |
Valuation
Trailing PE 102.24 | Forward PE 19.23 | Enterprise Value 2.31B | Price to Sales(TTM) 1.16 |
Enterprise Value 2.31B | Price to Sales(TTM) 1.16 | ||
Enterprise Value to Revenue 0.98 | Enterprise Value to EBITDA 40.63 | Shares Outstanding 127.73M | Shares Floating 108.95M |
Shares Outstanding 127.73M | Shares Floating 108.95M | ||
Percent Insiders 6.19 | Percent Institutions 100.31 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.